HE homepage

Illustration showing how procizumab captures circulating dipeptidyl peptidase 3 (cDPP3) to block this key molecular driver of shock. Illustrations courtesy of 4TEEN4

Procizumab was developed to change the trajectory of shock by addressing an underlying molecular driver rather than just managing symptoms.

Ransomware

Someone self-identifying as "Kazu" posted a sample of the data trove on a dark web forum, which was discovered by cybersecurity researchers. The company has not confirmed a data breach occurred.

Car accident head injury

The insurer claims personal injury attorneys referred patients to the network, where they allegedly received dubious treatments and undergo excessive testing to inflate medical claims. Allstate is seeking up to $5.2 million in restitution.

artificial superintelligence

Never mind artificial general intelligence. Worry about artificial superintelligence.

bipartisan house task force on artificial intelligence

With the U.S. Senate passing a funding agreement to reopen the federal government, the House of Representatives will now have a chance to make changes—though there’s little chance this particular amendment will succeed.

surgery

The family of Jeffrey Alan Fulcher, 58, sued the Medical University of South Carolina after the father of three died six days after undergoing a minimally invasive procedure to remove part of his esophagus. The state, on behalf of the hospital, settled the case out of court. 

Around the web

A new embolic protection device from Emboline was noninferior to the FDA-approved Sentinel device in terms of safety and efficacy. In addition, it captured much more TAVR-generated debris and was linked to an improved technical success rate.